NovoCure
NVCR
NVCR
218 hedge funds and large institutions have $1.37B invested in NovoCure in 2023 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 84 increasing their positions, 54 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
-7
Holders Change %
-3.11%
% of All Funds
3.2%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
45
Increased
84
Reduced
54
Closed
50
Calls
$30.9M
Puts
$35.4M
Net Calls
-$4.48M
Net Calls Change
-$15M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$57.7M |
| 2 |
Morgan Stanley
New York
|
$42.4M |
| 3 |
D.E. Shaw & Co
New York
|
$20.4M |
| 4 |
BlackRock
New York
|
$131M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$11.6M |
